Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Syntaxin binding protein 6 (STXBP6), also known as amisyn, is a 210-amino acid regulatory protein that serves as an essential component of the SNAP receptor (SNARE) complex. Located primarily in the cytoplasm and membrane, particularly in the Golgi apparatus, STXBP6 functions as a negative regulator of exocytosis by binding to syntaxin-1, syntaxin-4, and SNAP25 to form non-fusogenic complexes. This protein plays a critical role in neuronal vesicle trafficking, neurotransmitter release, and synaptic function. Mutations in STXBP6 represent a newly identified form of SNAREopathy that can lead to severe neurological conditions including developmental epileptic encephalopathy and autism spectrum disorders, making it an important target for understanding neurodevelopmental pathology.
Therapeutic approaches would likely focus on modulating its protein-protein interactions or expression levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Syntaxin binding protein 6 (STXBP6).